------------------------ Yahoo! Groups Sponsor --------------------~-->
Get fast access to your favorite Yahoo! Groups. Make Yahoo! your home page
http://us.click.yahoo.com/dpRU5A/wUILAA/yQLSAA/H4xqlB/TM
--------------------------------------------------------------------~->

Growth Areas in Biotech to be Highlighted at BIO InvestorForum in
San Francisco

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/

WASHINGTON, Oct. 5 BIO InvestorForum will focus on the
companies, clinical developments and research trends that are
considered to be
part of the "Growth Watch List" across the biotechnology sector. BIO
InvestorForum 2005 will take place at the Palace Hotel in San
Francisco,
October 18-20. The conference will be hosted by the Biotechnology
Industry
Organization (BIO), Bank of America and Lehman Brothers and co-
hosted by CIBC
World Markets, Jefferies and RBC Capital Markets.
BIO InvestorForum will highlight growth opportunity areas which
include
diabetes, hepatitis C, pain, lupus, cancer and cardiovascular
diseases and
areas of discussion will focus on clinical strategy, product
development and
the shifting regulatory landscape. Topics and issues comprising
the "Growth
Watch List" were developed by a special advisory board appointed
this year by
BIO comprised of industry thought leaders, buy-side investors, media
and
venture capitalists. (Please see list below.)
"While cancer, cardiovascular diseases and diabetes, will
continue to
garner research dollars in years to come, other diseases and
conditions like
lupus, sleep disorders, hepatitis C and pain are sparking much
interest in the
labs and among the investment community," said Morrie Ruffin, BIO's
executive
vice president of capital formation and business
development. "Investors,
clinicians and company CEOs will take a look at these areas of
research and
the clinical landscape affecting them at BIO InvestorForum."
Among other highlights will be Mark McClellan, administrator for
the
Centers for Medicare and Medicaid Services, who will deliver the
luncheon
keynote address Wednesday, Oct. 19.
The conference also provides investors and company
representatives a venue
to discuss potential partnerships and investment opportunities. This
year's
conference will feature 200 public and late-stage private company
presentations.
Other sponsors of the event include Aeterna Zentaris, Amgen,
Biogen Idec,
BioWorld Today, Cooley Godward, Dorsey & Whitney, Ernst & Young,
Ferskos,
Fulcrum Pharma Developments, Heller Ehrman, Knight Capital Group,
Latham &
Watkins, Merck, Pfizer, Pillsbury Winthrop Shaw Pittman, PR
Newswire, VWR
International, Wilson Sonsini Goodrich & Rosati with the support of
BayBio,
BIOCOM and BIOTECanada.
Media registration is complementary and can be completed in
advance by
clicking on investorforum.bio.org/opencms/bif/2005/index.jsp.
BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations
across the
United States and 31 other nations. BIO members are involved in the
research
and development of healthcare, agricultural, industrial and
environmental
biotechnology products.

BIO InvestorForum 2005 Advisory Board

Art Pappas, A.M. Pappas & Associates LLC
Jonathan MacQuitty, Abingworth Management Inc
Ron Cohen, Acorda Therapeutics, Inc.
J. Leighton Read, Alloy Ventures, Inc.
Craig Taylor, Alloy Ventures, Inc.
Farah Champsi, Alta Partners
Gerry Schaafsma, Anthem Capital Management, LLC.
Rodney Altman, Aphelion Capital
Peter Barrett, Atlas Venture
Jean-Francois Formela, Atlas Venture
Andrew Weisenfeld, Bank of America
Geert Cauwenbergh, Barrier Therapeutics, Inc.
Jeanne Cunicelli, Bay City Capital LLC
Karen Bernstein, BioCentury Publications Inc.
G. Steven Burrill, Burrill & Company
Matthew Perry, BVF Partners, L.P.
Peter Crowley, CIBC World Markets
Matthew Plunkett, CIBC World Markets
Barbara Kosacz, Cooley Godward LLP
James Sabry, Cytokinetics, Inc.
Deepa Pakianathan, Delphi Ventures L.P.
Bob More, Domain Associates, L.L.C.
Vera Kallmeyer, Equity4Health LLC
Michael Hildreth, Ernst & Young LLP
Gail Maderis, Five Prime Therapeutics, Inc.
Robert Overell, Frazier Healthcare Ventures
Kelly Holman, Genesys Capital Partners Inc
Rachel King, GlycoMimetics, Inc.
Bruce Jenett, Heller Ehrman LLP
Chris Ehrlich, InterWest Partners
Samuel Saks, Jazz Pharmaceuticals, Inc.
Annette Grimaldi, Jefferies
Rodney Ferguson, J.P. Morgan Partners, LLC
Vincent Aita, Kilkenny Capital Management, L.L.C.
Brook Byers, Kleiner Perkins Caufield & Byers
Ting Pau Oei, L Capital Partners
Matthew P. Young, Lehman Brothers
Nandini Tandon, MDS Capital Corp.
Pamela Demain, Merck & Co., Inc.
Ralph (Chris) Christoffersen, Morgenthaler Ventures
Ashley Dombkowski, MPM Capital L.P.
Michael Raab, New Enterprise Associates
Chris Shen, New Enterprise Associates
Hollings Renton, Onyx Pharmaceuticals, Inc.
Michael Sheffery, OrbiMed Advisors, LLC
Mark Carthy, Oxford Bioscience Partners
Douglas Fambrough, Oxford Bioscience Partners
Michael Lytton, Oxford Bioscience Partners
Gregory Martinez, Pequot Capital Management, Inc.
Marc-Henri Galletti, Pequot Ventures
Christopher Earl, Perseus-Soros BioPharmaceutical Fund, L.P.
Dennis Purcell, Perseus-Soros BioPharmaceutical Fund, L.P.
Alex Barkas, Prospect Venture Partners
Evan Melrose, PTV Sciences L.P.
P. Sherrill Neff, Quaker BioVentures, Inc.
Andrew Singer, RBC Capital Markets
Mike Ross, SV Life Sciences
George Schreiner, Scios Inc.
Jennifer Van Brunt, Signals Magazine
John Freund, Skyline Ventures
Nicola Campbell, Sofinnova Ventures, Inc.
Linda Rubinstein, Solexa, Inc.
Phyllis Gardner, Stanford University
Martin McGlynn, StemCells, Inc.
Daniel Swisher, Jr., Sunesis Pharmaceuticals, Inc.
Jay Markowitz, T. Rowe Price Associates
Bryan Roberts, Venrock Associates
Nancy Harrison, Ventures West Management, Inc.
Brian Atwood, Versant Ventures
Camille Samuels, Versant Ventures
Jonathan Leff, Warburg Pincus LLC

SOURCE BIO
Web Site: www.bio.org

http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
http://www.arizonabiotech.com/index.php
http://www.mail-archive.com/biotech-news@yahoogroups.com/
http://www.mail-archive.com/biotech-
news@yahoogroups.com/maillist.html

http://www.arizonabiotech.com/
<a href="http://www.arizonabiotech.com/">Arizona Biotech</a>
http://groups.yahoo.com/group/biotech-news/
<a href="http://groups.yahoo.com/group/biotech-news/">Biotech News</a>
http://www.arizonaentrepreneurs.com/
<a href="http://www.arizonaentrepreneurs.com/">Arizona Entrepreneurs</a>
http://www.azhttp.com/
<a href="http://www.azhttp.com/">Arizona High Tech</a>

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech